A digital program to improve lung cancer screening rates.
A Personalized Digital Outreach Intervention for Lung Cancer Screening
This study is testing a friendly mobile program called mPATH-Lung that helps current and former smokers learn about lung cancer screening and makes it easier for them to get screened by providing personalized support and information.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wake Forest University Health Sciences NIH-funded |
| Lab location | 1 site (Winston-Salem, United States) |
| Project ID | NIH-10788300 on NIH RePORTER |
What this research studies
This research aims to enhance lung cancer screening rates among high-risk individuals through a personalized digital outreach intervention. It addresses the barriers that prevent eligible patients from receiving screening by providing tailored information and decision-making support. The program, called mPATH-Lung, utilizes mobile technology to educate patients about lung cancer screening, its benefits, and risks, while also assisting healthcare providers in facilitating shared decision-making discussions. By leveraging digital tools, the research seeks to increase awareness and engagement in lung cancer screening among current and former smokers.
Who could benefit from this research
Good fit: Ideal candidates for this research are current and former smokers who are at high risk for lung cancer.
Not a fit: Patients who are not current or former smokers or those who do not meet the screening criteria may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase the number of high-risk patients who undergo lung cancer screening, potentially reducing mortality rates.
How similar studies have performed: Previous research has shown that digital outreach and decision aids can improve patient engagement and awareness in health screenings, indicating a promising approach.
Where this research is happening
Winston-Salem, United States
- Wake Forest University Health Sciences — Winston-Salem, United States (Active)
Researchers
- Principal investigator: Miller, David P — Wake Forest University Health Sciences
- Study coordinator: Miller, David P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.